Showing results (191-200 of 394) with videos related to
Sort By:
Pageof 40
The American Journal of Medicine|March 11, 2020
Contemporary Meta-Analysis of Extended Direct-Acting Oral Anticoagulant Thromboprophylaxis to Prevent Venous ThromboembolismVikas Bhalla, Olivia F Lamping, Ahmed Abdel-Latif, et al.Biochimica Et Biophysica Acta|July 28, 2012
Lipid phosphate phosphatase (LPP3) and vascular developmentH Ren, M Panchatcharam, P Mueller, et al.Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1983
Mammosomatotroph cell adenoma of the human pituitary: a morphologic entityE Horvath, K Kovacs, D W Killinger, et al.Clinical Cardiology|April 20, 2007
A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistanceJin Sun Lee, Steven P Dunn, Helen M Marshall, et al.The American Journal of Cardiology|August 8, 2018
Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized PatientsVikas Bhalla, Ahmed Abdel-Latif, Meenakshi Bhalla, et al.Cardiology in Review|December 2, 2014
Consensus review of the treatment of cardiovascular disease in people with hemophilia A and BVictor A Ferraris, Leonard I Boral, Alice J Cohen, et al.Journal of Thrombosis and Thrombolysis|June 17, 2020
Value-based assessment of implementing a Pulmonary Embolism Response Team (PERT)Rahul Annabathula, Adam Dugan, Vikas Bhalla, et al.Journal of the American College of Cardiology|October 16, 1999
Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potentialR C Becker, F A Spencer, Y Li, et al.The American Journal of Cardiology|July 13, 2001
Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])F A Spencer, R J Goldberg, P D Frederick, et al.Journal of Thrombosis and Haemostasis : JTH|April 17, 2012
A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agentJ P Vavalle, C P Rusconi, S Zelenkofske, et al.Pageof 40